A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Exercise as a Tool to Improve Response to Immunotherapy in Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC
- Status
- RECRUITING
- Phase
- NA
Feasibility Testing of a Dyadic Exercise Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers
- Status
- RECRUITING
- Phase
- NA
Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
- Status
- COMPLETED
- Phase
- N/A
Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
- Status
- COMPLETED
- Phase
- N/A
ArticuGrasp Trial: New Flexible Tool vs Standard Grasper for Lung Cancer Node Removal in Keyhole Chest Surgery
- Status
- COMPLETED
- Phase
- NA